Neuropathy refers to damage or dysfunction of peripheral nerves resulting in pain, numbness, tingling, and weakness. It can affect sensory, motor, or autonomic fibers and arises from metabolic, autoimmune, toxic, or genetic causes. Understanding neuropathy is vital for diagnosing early and preventing irreversible disability.

The Neuropathy session explores the underlying mechanisms, classifications, and diagnostic approaches for peripheral nerve disorders. Researchers discuss axonal degeneration, demyelination, and inflammatory neuropathies, emphasizing both clinical evaluation and molecular pathogenesis.

At the Neuropathy Conference, neurologists, endocrinologists, and pain specialists share case studies and therapeutic innovations. Topics include diabetic neuropathy, Guillain–Barré syndrome, hereditary sensory neuropathies, and small-fiber disorders.

This session is ideal for clinicians managing patients with chronic pain or sensory deficits and scientists investigating peripheral nerve biology. Attendees will learn to correlate electrophysiological findings with clinical symptoms and explore regenerative therapies.

Recent progress in Peripheral Neuropathy research highlights the use of nerve growth factors, electrical stimulation, and AI-based diagnostic algorithms to detect early micro-neuropathic changes.